Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.12 USD | -0.40% |
|
-0.98% | -20.60% |
06-27 | Dynavax Reports First Participant Dosed in Shingles Vaccine Trial | MT |
06-27 | Dynavax Technologies Corporation Initiates Phase 1/2 Study of Novel Shingles Vaccine Program | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.60% | 1.46B | |
+17.42% | 122B | |
+18.53% | 114B | |
+19.62% | 25.71B | |
-25.41% | 19.02B | |
-20.21% | 15.83B | |
-20.00% | 15.32B | |
-47.37% | 14.88B | |
+61.77% | 14.82B | |
+5.26% | 14.1B |
- Stock Market
- Equities
- DVAX Stock
- News Dynavax Technologies Corporation
- Transcript : Dynavax Technologies Corporation Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 10